(27) collected the clinical data of 116 patients with nasopharyngeal carcinoma with prognostic information and analyzed these data, and found that HMGA2 expression was significantly correlated with the overall survival time of patients with nasopharyngeal carcinoma, and the overall survival time of patients with high HMGA2 expression was significantly shorter than that of patients with low HMGA2 expression level, suggesting that high HMGA2 expression was associated with poor prognosis of patients with nasopharyngeal carcinoma. This evidence concerns the gene HMGA2 and nasopharyngeal carcinoma.